Takeda Pharmaceutical (TAK) Total Debt: 2018-2025

Historic Total Debt for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $29.6 billion.

  • Takeda Pharmaceutical's Total Debt fell 9.45% to $29.6 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $29.6 billion, marking a year-over-year decrease of 9.45%. This contributed to the annual value of $29.6 billion for FY2025, which is 11.75% down from last year.
  • Takeda Pharmaceutical's Total Debt amounted to $29.6 billion in FY2025, which was down 11.75% from $33.6 billion recorded in FY2024.
  • Takeda Pharmaceutical's 5-year Total Debt high stood at $45.9 billion for FY2021, and its period low was $29.6 billion during FY2025.
  • For the 3-year period, Takeda Pharmaceutical's Total Debt averaged around $31.9 billion, with its median value being $32.4 billion (2023).
  • Per our database at Business Quant, Takeda Pharmaceutical's Total Debt dropped by 16.19% in 2023 and then grew by 3.54% in 2024.
  • Takeda Pharmaceutical's Total Debt (MRY) stood at $45.9 billion in 2021, then fell by 15.60% to $38.7 billion in 2022, then fell by 16.19% to $32.4 billion in 2023, then rose by 3.54% to $33.6 billion in 2024, then decreased by 11.75% to $29.6 billion in 2025.
  • Its last three reported values are $29.6 billion in FY2025, $33.6 billion for FY2024, and $32.4 billion during FY2023.